FOR RESEARCHERS
RRP-ALSF Early Career Investigator (ECI) Grant
Application Deadline: Thursday, December 17, 2026 (8:00 PM ET)
The RRP-ALSF ECI Grant Program supports early-career scientists focused on inherited hematologic malignancy predisposition disorders, particularly RUNX1-FPD.
This program provides funding to advance innovative research aimed at intercepting disease-associated processes that lead from a premalignant state to overt hematologic malignancy in RUNX1-FPD patients.
Application Information
Review the complete eligibility requirements, funding details, and application instructions before applying.
Applications will be submitted through Alex’s Lemonade Stand Foundation’s online grant portal. We will add the link here when it opens.
Click here to see past RRP-ALSF ECI grantees and funded research projects
Funded Research Portfolio Overview
Our Research Partners
RRP Research Impact
RRP Cancer Interception/ Prevention Research Roadmap
Our roadmap is simple. We only invest in research that brings us one step closer to our end goal. We understand that discovering medicines requires the right tools (i.e. disease models and laboratory reagents) and the right datasets (i.e. patient clinical and genomic data, as well as patient biospecimens). We have defined 4 rational therapeutic approaches to preventing blood cancer:
1) selectively targeting precancerous cells;
2) increasing RUNX1 activity;
3) decreasing cancer-causing inflammation;
4) fixing or replacing RUNX1-mutated cells using cell or gene therapy.
4 Rational Therapeutic Approaches to Cancer Interception/Prevention
